3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow glycopyrronium bromide: new trials by email Literature Review of glycopyrronium bromide trials Research Report on glycopyrronium bromide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clozapine-induced Hypersalivation - Feasibility Trial Hyoscine, Glycopyrrolate, Placebo - Sialorrhea | Phase 1 / Phase 2 | Completed | Mersey Care NHS Trust | 29 | 2016-01-25 | 2018-02-28 |
| Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease glycopyrronium bromide - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Prosonix Limited | 37 | 2013-05-01 | 2016-03-30 |
| Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease NVA237 100 µg, Placebo, NVA237 200 µg - Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Completed | Novartis | 281 | 2007-08-01 | 2012-05-21 |
Pulmonary Disease, Chronic Obstructive (2) · Schizophrenia, Treatment-Resistant (1) · Sialorrhea (1)
Mersey Care NHS Trust (1) · Novartis (1) · Prosonix Limited (1)
United Kingdom (2) · France (1) · Germany (1) · Netherlands (1) · Spain (1) · Turkey (Türkiye) (1) · United States (1)
Dave Singh, MA MD MRCP (1) · Geoff Down, MB BS FFPM (1) · Inti Qurashi, MBChB (1)